Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.
about
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionGenome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis ConsortiumInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionEndocannabinoid signalling in reward and addiction.Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues.Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families.Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysisConsidering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults.The Genetics, Neurogenetics and Pharmacogenetics of AddictionLinkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family studyMore aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation.Reactivity to in vivo marijuana cues among cannabis-dependent adolescentsCraving Cannabis: A Meta-analysis of Self-Report and Psychophysiological Cue-Reactivity Studies.Linkage analyses of stimulant dependence, craving, and heavy use in American Indians.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals.Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adultsContributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis usersMonoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysisA preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.Cannabis cue-elicited craving and the reward neurocircuitry.Candidate genes for cannabis use disorders: findings, challenges and directionsGenetic and Environmental Factors Associated with Cannabis Involvement.Marijuana craving in the brain.Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.Acute Effects of Marijuana Smoking on Negative and Positive Affect.Cue-induced craving for marijuana in cannabis-dependent adults.Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results.The genetic basis of the endocannabinoid system and drug addiction in humans.Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases.Common single nucleotide variants underlying drug addiction: more than a decade of research.Cannabis and development of dual diagnoses: A literature review.Whole genome sequence study of cannabis dependence in two independent cohorts.Validation of the French version of the marijuana craving questionnaire (MCQ) generates a two-factor model.Pharmacogenetics of Cannabinoids.Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias.
P2860
Q27014154-64829E0E-6FF5-43F3-B512-8114E3C78823Q28274406-253CF548-EE1D-4529-93C7-D9AC5BA0E0D1Q28283718-407C2243-C5ED-4AC9-8DD0-50B6308D5C8FQ30373359-2A890F90-D488-4F59-89AE-E8E5FF6D6144Q33645739-694D62CC-DDC9-438E-99DE-511EC9D124B4Q33727978-34E2F6FA-A6AD-42CC-B90E-AD2014D008A1Q33824425-B15E779B-81AD-4DC8-A536-40AF82E63735Q33855815-3AF7E6E1-FEC3-4984-8204-D0AF81477C84Q33898930-B10671BA-5149-4906-BEEE-99FFF8425AAAQ34133171-886E33E7-C652-4401-A412-BA3031106C35Q34156619-830DFF03-C364-4072-842B-47C591DA09ABQ34252749-1F249847-5867-4799-8300-BE2F62255761Q34311287-C5512685-816F-4215-953A-E56646092A71Q34528740-FF7C710C-AC88-41FC-AF84-1957FE53E4C8Q35288165-F99125A3-13D3-4306-AAE6-250FA8A88028Q35532072-9F95FC89-41D1-43D1-8FBB-B78297065D8DQ35533136-069D1811-820A-4D26-9D4D-178EB2FE3EAFQ35685476-E18F79A9-6F9D-4612-9C4E-DA767FA6E9F4Q35757921-9E46CC8A-2883-4C22-9133-44F5D6FAE536Q35784024-B8FE2064-3EA5-493C-AC12-B2D48881A224Q35921532-58F98AA0-7656-4C49-A388-345CF09A2C2FQ36234299-E4D2F8BF-B62B-4E70-BA4E-9B13ABEFD209Q36429054-4B02B50A-D7B6-4A4D-B61D-7AD84020A2CFQ36530819-45469D57-2872-490B-A682-AE002482879BQ36757474-B63B0819-262A-430D-A226-39DEFFC06CB9Q37245382-9A336410-6DDE-4DBA-AD49-F7C1977F2B17Q37249137-BDC33115-A0B2-488D-BC16-B53E92B13888Q37276776-C2CAAC1E-6B5D-4A51-A701-69296D720A22Q37278686-B1B1CC1A-99B9-4650-A313-DA83D523B30AQ37366043-0701B1DF-5BDC-4051-ACD5-9ADB46ECC7BCQ37420477-E796D84E-084B-4028-9680-3E8024D6092FQ37524784-FA408D86-A8DE-435B-9084-D9A8D1E96C91Q37936694-0ECC8DC4-74B8-476E-B91C-C6F5A75A2092Q38072055-31F8131C-3C58-4F26-A2F2-AEE84D437627Q38325368-98D1344B-9EDB-47E4-B9A7-38B53D439DB5Q38950359-2558660B-14C4-4B5F-8256-A5B61140FE0FQ39006186-36FC5273-57DC-4C76-8816-BC7468D9DABCQ39197418-7229FB63-8C63-46E5-B94E-D9A17CDB8C4DQ39324195-193D1B6E-9D6B-472C-9C39-550CE829CF55Q41640409-0FC01897-0C7E-4DC3-B7CC-C38A03484A04
P2860
Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@ast
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@en
type
label
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@ast
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@en
prefLabel
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@ast
Marijuana withdrawal and cravi ...... amide hydrolase (FAAH) genes.
@en
P2093
P2860
P921
P1433
P1476
Marijuana withdrawal and cravi ...... d amide hydrolase (FAAH) genes
@en
P2093
Ashleigh Louis
Erin Marshall
Heather M Haughey
Kent E Hutchison
P2860
P304
P356
10.1111/J.1360-0443.2008.02292.X
P407
P577
2008-08-14T00:00:00Z